Skip to main content
. 2014 Feb 21;20(7):1833–1838. doi: 10.3748/wjg.v20.i7.1833

Table 2.

Colon findings from the PTEN hamartoma tumor syndrome cohort and systematic review

Author OSU cohort Levi et al[19] Coriat et al[18] Stanich et al[16] Heald et al[14] Kim et al[17] Total, all patients Percentage Total, + PTEN mutation Percentage
n, with colonoscopy 5 10 10 10 67 5 107 88
PTEN mutation 4 10 NR 5 67 2 88 82% 88 100%
Age (yr), mean 45.8 31.7 37 48 36.4 34 37.4 36.9
# of colonoscopies, mean 4.2 2.4 3.1 2 NR NR 2.7 2.9
Patients with colon polyps 5 8 10 9 62 5 99 92.5% 81 92%
> 50 polyps 1 NR 8 7 NR NR 16 64% 5 55.6%
Pancolonic location 3 7 7 8 NR NR 25 71.4% 14 73.7%
Left-sided location 2 1 NR 1 NR NR 4 16% 3 15.8%
n, with colonic pathology 4 8 10 11 56 5 94 75
Adenocarcinoma 0 1 0 2 9 0 12 12.8% 12 16%
Adenoma 2 3 10 6 16 1 38 40.4% 24 32%
Ganglioneuroma 1 3 5 6 16 0 31 33% 23 30.7%
Hamartoma 0 5 6 7 18 0 36 38.3% 27 36%
Hyperplastic 2 8 0 4 27 0 41 43.6% 39 52%
Inflammatory 0 0 0 7 11 5 23 24.5% 18 24%
Juvenile 1 2 0 2 0 0 5 5.3% 5 6.7%
Lymphoid hyperplasia/polyp 0 0 0 0 4 1 5 5.3% 5 6.7%
Sessile serrated polyp 0 0 0 0 2 0 2 2.1% 2 2.7%
1 polyp type 2 1 NR 2 29 3 37 44% 32 42.7%
2 polyp types 2 4 NR 2 16 2 26 31% 25 33.3%
≥ 3 polyp types 0 3 NR 7 9 0 19 22.6% 16 21.3%

NR: Not reported.